DMRA analyst estimates
Damora Therapeutics (DMRA) analyst ratings, the average price target and its range, and every firm's latest call.
- 3 firms rate DMRA: 3 buy, 0 hold, 0 sell.
- The average price target is $52.50 from None analysts, from $40.00 to $60.00.
Updated 2026-11-10 04:45 UTC